Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, I'll be doggone......thought for sure I'd be fishing for alot longer than this.
OT: We will see won't we?
I think it was because he did a fine job of controling this thread today.....what a guy!
jrod....to your face....your dripping with your ego again...we just can't seem to get away from it....but I can...see you in iggyland
A real long would say forget the last few days...in a year this stock is gonna change lives for those suffering from the disease and those investing in it. A trader will say we're on our way.
We know they are there and they know we are here. They'll use us and we'll use them. If everyone does their best toward a single goal, we have no more worries. You and I are on the same page and that's what matters. Things are looking great.
I think your seeing plenty of support from the company by NOT putting out fluffy PRs....Let's not rehash that....Let's wait and see if we stair step up to continually new trading ranges and let them show us their support and honesty by following thur on what they have already PR'd. That's the kind of reality that I hope for in a stock. By the looks of things, I don't EVEN have a fleeting thought that I'm not in on the ground floor of a monsterous pharma.
I must admit....I have used your Jack Nickolson sound bite several times today. Now THAT was humorous.
Yes, silly sandbox mannerisms...those were the days.
To jrod, visitor from another planet. Off Topic.
Don't open my eyes too far....my eyeballs will fall out.
Any time of year is perfect....I hear they have excellant launch and LZs for the kites. And can stay up all day on the thermals
jrod....you are soooo insecure. Picking thru conversations to find anything that will help your selfesteem. GLTY
jrod....if toaddy is on your side that pretty well seals the deal that you have the same agenda. The further the PPS goes up the madder ya'll are goin to get. To bad you have to resort to the sandbox mannerisms, which just brings you lower on your popularity. Take notice of chartists here that we do like...they are getting more and more popular because of you. Go figure.
Thanks again Dart....looking good
I knew you couldn't stay away. Cant stand to lose, can ya. Your chart skills are worthy. Your personality, on the other hand, really sucks.
This is getting kinda obvious.
I'm sure Dart is getting a kick out of it too. That's too funny.
Yeah...he was a real pip.
Thanks Dart.....always a pleasure to see your charts. Couldn't have had better timing....and luv your signature.
I think if he had entered the board with less fact stating and more positive interacting with long board members it would have been the beginning of a informative relationship. Instead, he stomped into the board and the first friend he made was someone that could care less about the stock. You tell me.
jrod, I have reservations about your ride with us to the top. You have very respectable knowledge of charts and their movements. That is an asset in any investors book. There are also chartist among the longs here and they are just as knowledgable. They will discuss and debate among others here and have earned our respect AND will also be here with us when this stock is at $5 a share, no matter how long that takes. Your "I know all so don't question it" mentality has got me and others here a bit put off. The fact that you laughed in my face when I asked for alittle coutesy when posting your info so I could try and absorb it without standing on my head with the scrolling crap kinda tilted my attitude.....along with your immediate association with penny, who has been anything but pleasant in her attitude toward us or the stock. Just seemed you were trying to find a following here. That being said, buy as much XKEM as you can and enjoy the ride to riches with us...or not.
penny, you stated:
"XKEM - I dont chase...certainly not when a stock is being pumped overzealously over a weekend such as XKEM just was :)
Many better plays out there."
And then you said:
"I never said XKEM is a poor investment...LOL"
So, I assume there is a happy medium you'd like to tutor us on...the better plays and why. Being more specific on the pumping.
Understand....cool. I get e-mail that goes on forever from people that I enjoy conversing with and will end up deleting because of the scrolling. I enjoy all info from doctors to chartists and will try to soak up all I can. Whether I take the info to heart depends on my perspective. Some are more conservative than I. Many pieces to the investing puzzle...always learning. Must have input.
Sorry to raise your haunches there dog...I'll try to be MORE polite next time!
posting so that I don't have to scroll horizontally...unless I'm the only one having the problem...then I'll have to figure it out from here.
could you post to the margins of the board...you have alot to say and I have to scroll alot to read it all. TIA
I agree with that too....there are too many presents in Santa's bag and he could be coming very early this year. That's why I'm taking my targets off the table and riding this to the loan news or stockholders meeting and/or any surprises, then reevaluating. This upcoming conference could be one of the surprises.
I respect and am studying your resistance and support levels. BUT, they may fly out the window if there's a monsterous run. Until then I will have your results in front of me and thank you for the DD.
Thanks for reminding us about the Q & A. I think it will start to apply more and more starting this week up to the stockholders meeting. For those that are new and just for a nice reminder of what we expect in the near future, here it is:
Posted by: CowboyBaby
In reply to: None Date:9/13/2006 8:55:52 PM
Post #of 49638
I just read through this PR again where Dr.Pandey responded to shareholders and the business community. It doesn't hurt to read through once again and understand the fundamentals of this soon to be huge Pharma company.
Xechem Chairman Responds to Shareholder Questions Regarding NICOSAN(TM) Progress and Sales Forecasts
The Chairman of Xechem International, Inc. (OTC BB: XKEM), Dr. Ramesh C. Pandey, responded today to a number of questions posed by investors and others in the business community concerning the status of its operations in the aftermath of the approval of NICOSAN(TM), its sickle cell drug, by Nigerian regulators on July 3rd, 2006. Some of the questions posed to the company and answered by Dr. Pandey are the following:
--------------------------------------------------------------------------------
Status of Production Facility
Q1: Xechem has reported that its Sickle Cell Drug, NICOSAN(TM), is
being produced in limited quantities at its pilot scale facility
in Abuja, and that construction has now begun on its full scale
facility at the same location. When do you expect the full scale
facility to be completed and at what cost?
A1: We estimate that the construction of the new facility will be
completed in approximately nine to twelve months, subject to
timely receipt of the required funds, and the facility will be
fully operational then. Our current estimate is that the total
cost of the new facility, including the cost of the required
machinery and equipment, will be approximately $12 to $15 million,
of which over $5 million has already been invested by the Company.
Expected Sources of Funding
Q2: What are the sources of the expected funding to finance the
capital expenditures?
A2: In the past several weeks, we received a loan from NEXIM Bank of
Nigeria for 150 million Naira (USD $1.2 million). The bulk of
those proceeds have been earmarked for the initial phase of
construction, and that work has recently begun. NEXIM has been an
extremely supportive lender that likes very much what Xechem is
doing in Nigeria and has expressed a strong interest in investing
significantly more money into Xechem's operations there. In fact,
advanced discussions are now underway with NEXIM officials
concerning a substantial new loan, the proceeds of which would be
used primarily for constructing the buildings for the new
commercial scale facility. We are also continuing to aggressively
pursue an approximately $8 to $9 million loan through the U.S.
Export-Import Bank Loan Guarantee Program.
Q3: Can you provide a report on the status of the Ex-Im loan and the
likelihood that it will close in the near future?
A3: As with any significant commercial loan to a company at our stage
of development, issues arise during the course of negotiation and
due diligence that can affect the timing of any proposed
transaction. This was especially true prior to July 2006, when we
received regulatory approval from Nigeria's National Agency for
Food and Drug Administration and Control (NAFDAC). That approval
added quite a bit of credibility to our efforts, particularly in
procuring the required local Nigerian bank guarantee, and has
seemed to accelerate the pace of negotiations with the various
parties involved with the Ex-Im guaranteed loan. Although
certainly there are no assurances as to when or if this loan will
close, I believe we have satisfied all of the statutory and other
requirements for the transaction and my sense is that this loan
has an excellent chance of being approved in the near future.
Q4: Do you believe the government of Nigeria may step up and agree to
provide financial support to Xechem in one form or another?
A4: In my judgment, the government of Nigeria has an incentive to
offer financial support to Xechem for at least three important
reasons. First, we have licensed our product from Nigeria's
National Institute for Pharmaceutical Research and Development
(NIPRD), which stands to benefit directly from our financial
success through the gross royalty they will receive from the sale
of our product. Second, there is no place in the world where
NICOSAN(TM) is more desperately needed than Nigeria and I believe
that the government has a strong incentive on humanitarian grounds
to help insure that the drug reaches as many of its citizens as
can be accomplished. And third, Nigeria is working very hard to
improve its image internationally and to promote corporate
investment, especially by American companies. The government of
Nigeria knows that Xechem is being closely watched by investors
and others in the business community who want to see if an
American company like Xechem can be truly successful in Nigeria.
For all of these reasons, I believe that the government of Nigeria
would consider offering Xechem substantial financial support in
one form or another under the right circumstances .
Q5: Has Xechem already approached the Nigerian government about the
possibility of providing Xechem some form of financial
accommodation?
A5: As with many aspects of the development of our business, until our
drug was formally approved by the regulators in Nigeria, it was
impossible to have meaningful dialogue concerning possible
governmental support for Xechem in whatever form. Now that the
drug has been approved, those doors have been opening, in some
case widely, and that has been the case concerning possible
governmental support. While I cannot speak to the details of those
discussions or comment on the possible timing or likelihood of
working directly with the government to support our operations
financially, I can say that we are having high level conversations
with government officials concerning a possible pre-purchase of
large scale quantities of our product for distribution by the
government in the country's national hospitals.
Current and Projected Sales Activity
Q6: Turning to the drug itself, have sales of the product begun and,
if so, how is the drug being distributed?
A6: We have begun sales of the product on a limited basis in Abuja.
Because we are producing pilot scale quantities which are
insufficient to meet the expected demand for the product, we have
strictly limited distribution of the drug so that, at present, it
can only be acquired at Xechem Nigeria's headquarters at Sheda
Science and Technology Complex (SHESTCO), Abuja. Soon, we expect
to open three to four satellite offices in Abuja. These measures
will last until the full scale facility is completed when we will
turn to more traditional avenues of marketing and distribution
throughout Nigeria and beyond. Keep in mind that once on the
medicine, a patient must continue taking it on a daily basis
without interruption in order for the drug to be effective. One of
our big concerns is making sure that once a patient begins taking
the medicine, that person will have uninterrupted access to the
drug going forward.
Q7: How many patients do you expect to serve before the completion of
the full-scale facility?
A7: Based on the quantities of the finished product now on hand and
our current small-scale production capability, we project that we
will be able to meet the needs of approximately 20,000 patients
per month on an annualized basis pending completion of the
full-scale facility.
Q8: What is the current price for the drug and what sales volume do
you forecast for this initial period prior to full-scale
production?
A8: We are currently charging 3000 Naira (USD $23) per month for adult
patients and 2400 Naira (USD $18.50) per month for children. If we
meet our target of supplying 20,000 patients per month on average
during the first year, this will result in annual sales of
approximately $5 million during this period of limited production
capability. That number could be significantly higher if, as we
expect, we are successful in achieving some incremental increase
in capacity between now and the time the full-scale facility is
completed.
Q9: Once the expanded production facility is completed, what do you
feel is the market potential for this drug?
A9: There are approximately 4 million people in Nigeria alone
afflicted with Sickle Cell Disease, of whom we believe upwards of
50% live in urban or quasi-urban areas where average income levels
are believed to be sufficiently high to absorb the retail cost of
the product. Realistically, we believe we should be able to
penetrate more than half of that segment of the market over a five
year period, which would result in estimated annual revenues to
Xechem Nigeria of approximately $200 million at today's prices.
And that is for Nigeria alone. Needless to say, down the road, we
expect to generate additional revenues from sales of the product
throughout Africa, not to mention India and the Middle East and,
of course, Europe and the United States. Also, these figures do
not take into account additional sales that may be possible to
poorer segments of Nigerian society as part of a pre-purchase or
other support program with the government of Nigeria.
Q10: Can you speak to the substantial decline in the price of Xechem
stock that has occurred since the launch?
A10: There are many theories on that, and it's probably best for me
not to address them directly. What I do feel comfortable in saying
is that we have something very special going on in Nigeria right
now and have unquestionably accomplished a great deal in getting
to this point in spite of the many obstacles in our path. I am
confident that as we secure one or more traditional bank type
financings and move forward in the implementation of our business
plan, things will change markedly for Xechem and its shareholders.
My message to our shareholders is this: the patient investor will
be rewarded as we progress toward full scale production of this
historical drug.
OT...Just for the fun of it.
Mike decided to go skiing with his buddy, Bob. So they loaded up Mike's minivan and headed north. After driving for a few hours, they got caught in a terrible blizzard that consumed the countryside. So they pulled into a nearby farm and asked the attractive lady who answered the door if they could spend the night.
"I realize it's terrible weather out there and I have this huge house all to myself, but I'm recently widowed," she explained. "I'm afraid the neighbors will talk if I let you stay in my house..."
"Don't worry," Mike said. "We'll be happy to sleep in the barn. And if the weather breaks, we'll be gone at first light." The lady agreed, and the two men found their way to the barn and settled in for the night.
Come morning, the weather had cleared and they got on their way. They enjoyed a great weekend of skiing.
But about nine months later , Mike got an unexpected letter from an attorney. It took him a few minutes to figure it out, but he finally determined that it was from the attorney of that attractive widow he had met on the ski weekend.
He dropped in on his friend Bob and asked, "Bob, do you remember that good-looking widow from the farm we stayed at on our ski holiday up north about 9 months ago?"
"Yes, I do." said Bob.
"Did you, er, happen to get up in the middle of the night, go up to the house and pay her a visit?"
"Well, um, yes," Bob said, a little embarrassed about being found out "I have to admit that I did."
"And did you happen to use my name instead of telling her your name?"
Bob's face turned beet red and he said, "Yeah, look, I'm sorry, buddy. I'm afraid I did. Why do you ask?"
"She just died and left me everything."
(And you thought the ending would be different, didn't you?... now I hope you keep that smile for the rest of the day.)
analitic....why would you post that when it said before the bell when it came out a year ago>??? just looking for attention?....good info, bad motive.
Oh, and scarecrow got banned....a positive event for sure.
Sure piglet...anything u want.
Thanks....he's really becoming such a scab
The answer is yes...so hard for people to see that...so easy to figure tho.
BLAST OFF
Drifter, I'd first like to apologize for tangling with you the other day...I'm relatively new here and just learning to play well with others.
To address the restriction that we're being subject to, I have a theory. I just sold off another stock that Ameritrade had restricted and Amerit. gave me a duh answer, just like we're getting. THAT stock went from .03 to .40 and I made out like a bandit. I, however DO know why it happened because I know the right people inside the company. They told me that it's not public info and I agreed to not say why publicly. My profits from my sells were made before I knew what I know so I can't be held accountable for using inside info. I can say this tho...there are forces at work that may not seem like they're on your side but are very much so. Maybe I can explain it this way. If you show a dog a steak...let em sniff it, lick it and then take it away you have a begging dog. Everybody on this board was pissed because they had to go thru a broker to trade. That made them want to trade even more. There was a slow down in trading because of broker assisted trading. That also was working with you tho I don't totally understand that part of it. The SEC is working with you not against you in this instance. AND there is a warning to certain MMs when this happens. To get more out of what I just said, ask your biker friend if any of this makes sense to him. And then ask anyone else who has had a stock restricted if there wasn't a "cleansing" and a sharp rise in PPS because of it. ALSO, notice we went up on low volume....how often does that happen??
There you go again....hitting the nail on the head. Supply and demand is the catalist. The restriction slowed it down thus causing the squeeze. Sure would like to know who introduced THAT right at this time. Some more of that mysterious influence that I think we're gonna see more of. Maybe time to saddle up and pull that cinch tight.